Literature DB >> 18818586

Progress toward measles elimination--Japan, 1999-2008.

.   

Abstract

In 2005, the Regional Committee of the World Health Organization (WHO) Western Pacific Region (WPR) set a target date of 2012 for measles elimination in all WPR member states. In Japan, measles control strategies have included 1) a nationwide public awareness campaign implemented in 2001 to promote timely vaccination with the first dose of measles-containing vaccine (MCV1) administered on or after age 12 months, and 2) a 2-dose MCV schedule with the second dose (MCV2) administered at age 5-6 years, adopted in 2006 in accordance with the recommended WPR measles elimination strategy. However, during 2007-2008, Japan experienced a large measles outbreak, which resulted in exportation of measles cases from Japan into countries where measles elimination had been achieved. This report describes the epidemiology of measles in Japan during 1999--2008 and approval of a National Measles Elimination Plan in December 2007 that includes recommendations for immunization strategies, case-based measles surveillance, and monitoring to ensure elimination of measles by 2012. Measles continues to be endemic in Japan, with most cases occurring in children before school entry, except for 2007 and 2008, when a shift to an older age group was observed. With implementation of the National Measles Elimination Plan, Japan is expected to make progress toward achieving the WPR measles elimination goal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818586

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

Review 1.  A review of factors affecting vaccine preventable disease in Japan.

Authors:  Norimitsu Kuwabara; Michael S L Ching
Journal:  Hawaii J Med Public Health       Date:  2014-12

2.  Contribution of matrix, fusion, hemagglutinin, and large protein genes of the CAM-70 measles virus vaccine strain to efficient growth in chicken embryonic fibroblasts.

Authors:  Luna Bhatta Sharma; Shinji Ohgimoto; Seiichi Kato; Sekiko Kurazono; Minoru Ayata; Kaoru Takeuchi; Toshiaki Ihara; Hisashi Ogura
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

3.  The economic disease burden of measles in Japan and a benefit cost analysis of vaccination, a retrospective study.

Authors:  Kenzo Takahashi; Yasushi Ohkusa; Jong-Young Kim
Journal:  BMC Health Serv Res       Date:  2011-10-07       Impact factor: 2.655

Review 4.  Vaccine chronicle in Japan.

Authors:  Tetsuo Nakayama
Journal:  J Infect Chemother       Date:  2013-07-09       Impact factor: 2.211

5.  Antibody Response to Live Attenuated Vaccines in Adults in Japan.

Authors:  Taku Ogawa; Fukumi Uchiyama-Nakamura; Aiko Sugata-Tsubaki; Yutaka Yamada; Kenji Uno; Kei Kasahara; Koichi Maeda; Mitsuru Konishi; Keiichi Mikasa
Journal:  Open Med (Wars)       Date:  2016-11-26

6.  Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy.

Authors:  S Kumakura; H Shibata; K Onoda; N Nishimura; C Matsuda; M Hirose
Journal:  Epidemiol Infect       Date:  2013-04-11       Impact factor: 2.451

7.  An investigation of a measles outbreak in Japan and China, Taiwan, China, March-May 2018.

Authors:  Kazuki Shimizu; Ryo Kinoshita; Keita Yoshii; Andrei R Akhmetzhanov; Sungmok Jung; Hyojung Lee; Hiroshi Nishiura
Journal:  Western Pac Surveill Response J       Date:  2018-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.